← Back to Search

Single Arm Cohort Receiving Digital Health Coaching for Mantle Cell Lymphoma

N/A

Waitlist Available

Led By Sherry Adkins, MSN

Research Sponsored by Pack Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up enrollment, months 1, 3, 6

Awards & highlights

Study Summary

This trial is evaluating the feasibility of a digital health coaching program to help people manage CAR T cell therapy.

Eligible Conditions

Mantle Cell Lymphoma
Lymphoma
Multiple Myeloma
B-Cell Lymphoma
Follicular Lymphoma
Acute Lymphoblastic Leukemia
Leukemia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ enrollment, months 1, 3, 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~enrollment, months 1, 3, 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment, months 1, 3, 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Feasibility of the intervention

Secondary outcome measures

Cancer Behavior Inventory (CBI-B)

Functional Assessment of Cancer Therapy-Lymphoma (FACT-Lym)

National Institutes of Health (NIH) Patient Reported Outcomes Measurement Information System (PROMIS) Global Health 10

+1 more

Other outcome measures

Digital Engagement

Health Care Utilization

Socio-demographic, clinical, and treatment characteristics

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single Arm Cohort Receiving Digital Health CoachingExperimental Treatment1 Intervention

All study participants will be enrolled in a 6-month digital health coaching program.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Pack HealthLead Sponsor

5 Previous Clinical Trials

1,118 Total Patients Enrolled

M.D. Anderson Cancer CenterOTHER

2,966 Previous Clinical Trials

1,804,731 Total Patients Enrolled

Bristol-Myers SquibbIndustry Sponsor

2,638 Previous Clinical Trials

4,128,464 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment capacity for this clinical research?

"Affirmative. The information found on clinicaltrials.gov attests that the recruitment of individuals for this trial is still taking place, having been originally posted on March 11th 2022 and last updated April 12th 2022. 50 participants are sought from 1 medical site."

Answered by AI

Are there any eligibility requirements for participation in this clinical trial?

"Yes, according to clinicaltrials.gov, this research is presently in search of qualified individuals. This trial was posted on March 11th 2022 and has since been revised as recently as April 12th 2022. There are 50 available slots at a single medical centre."

Answered by AI

What positive effects is this trial expected to have?

"The primary aim of this research study, which will be measured up to 6 months post-treatment, is to measure patient Acceptability. Secondary objectives include establishing a 5 question Subjective Assessment of CAR T Management that utilizes a 9 point scale from 1 "Not at all confident" to 9 "Confident", using the Cancer Behavior Inventory (CBI-B) 12 item instrument with confidence responses ranging 1 -9 and assessing quality of life through the Functional Assessment of Cancer Therapy Lymphoma (FACT Lym) 42 question survey."

Answered by AI

Recent research and studies

Supportive Care in CancerJournal

Feasibility of a Psychosocial and Patient Navigation Intervention to Improve Access to Treatment Among Underserved Breast Cancer Patients

Madore, Shannon, Kristin Kilbourn, Patricia Valverde, Evelinn Borrayo, and Peter Raich. 2014. “Feasibility of a Psychosocial and Patient Navigation Intervention to Improve Access to Treatment Among Underserved Breast Cancer Patients”. Supportive Care in Cancer. Springer Science and Business Media LLC. doi:10.1007/s00520-014-2176-5.

American Journal of Health BehaviorJournal

Multiple Health Behavior Change in Adults with or at Risk for Cancer: A Systematic Review

Green, Amanda C., Laura L. Hayman, and Mary E. Cooley. 2015. “Multiple Health Behavior Change in Adults with or at Risk for Cancer: A Systematic Review”. American Journal of Health Behavior. JCFCorp SG PTE LTD. doi:10.5993/ajhb.39.3.11.

Journal of the Advanced Practitioner in OncologyJournal

Educating Multidisciplinary Care Teams, Patients, and Caregivers on CAR T-cell Therapy

Beaupierre, RN, BSN, OCN, Alix, Nicole Kahle, MS, RN, OCN, BMTCN, Rachel Lundberg, PA-C, MPAS, and Amy Patterson, MSN, APRN, AOCNS, BMTCN. 2019. “Educating Multidisciplinary Care Teams, Patients, and Caregivers on CAR T-cell Therapy”. Journal of the Advanced Practitioner in Oncology. Harborside Press, LLC. doi:10.6004/jadpro.2019.10.4.12.

Hematological OncologyJournal